AN EVALUATION OF EPIDERMAL GROWTH FACTOR RECEPTOR INHIBITORS AND ANGIOGENESIS INHIBITORS AS TARGETED THERAPY IN POOR PROGNOSIS ENDOMETRIAL CANCER

Project Details

Short titleAN EVALUATION OF EPIDERMAL GROWTH FACTOR RECEPTOR INHIBITORS AND ANGIOGENESIS INHIBITORS AS TARGETED THERAPY IN POOR PROGNOSIS ENDOMETRIAL CANCER
StatusFinished
Effective start/end date1/05/08 → 30/04/10

Funding

  • Gloucestershire Hospitals NHS Foundation Trust